Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.
Tallón de Lara P, Cecconi V, Hiltbrunner S, Yagita H, Friess M, Bode B, Opitz I, Vrugt B, Weder W, Stolzmann P, Felley-Bosco E, Stahel RA, Tischler V, Britschgi C, Soldini D, van den Broek M, Curioni-Fontecedro A. Tallón de Lara P, et al. Among authors: friess m. Clin Cancer Res. 2018 Dec 15;24(24):6345-6354. doi: 10.1158/1078-0432.CCR-18-1231. Epub 2018 Aug 28. Clin Cancer Res. 2018. PMID: 30154226 Free article.
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.
Bitanihirwe BK, Meerang M, Friess M, Soltermann A, Frischknecht L, Thies S, Felley-Bosco E, Tsao MS, Allo G, de Perrot M, Seifert B, Moch H, Stahel R, Weder W, Opitz I. Bitanihirwe BK, et al. Among authors: friess m. J Thorac Oncol. 2014 Feb;9(2):239-47. doi: 10.1097/JTO.0000000000000055. J Thorac Oncol. 2014. PMID: 24419422 Free article.
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
Meerang M, Bérard K, Friess M, Bitanihirwe BK, Soltermann A, Vrugt B, Felley-Bosco E, Bueno R, Richards WG, Seifert B, Stahel R, Weder W, Opitz I. Meerang M, et al. Among authors: friess m. Mol Oncol. 2016 Oct;10(8):1255-65. doi: 10.1016/j.molonc.2016.06.005. Epub 2016 Jun 25. Mol Oncol. 2016. PMID: 27378628 Free PMC article.
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients.
Pavic M, Bogowicz M, Kraft J, Vuong D, Mayinger M, Kroeze SGC, Friess M, Frauenfelder T, Andratschke N, Huellner M, Weder W, Guckenberger M, Tanadini-Lang S, Opitz I. Pavic M, et al. Among authors: friess m. EJNMMI Res. 2020 Jul 13;10(1):81. doi: 10.1186/s13550-020-00669-3. EJNMMI Res. 2020. PMID: 32661672 Free PMC article.
55 results